ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Yearbook of Pediatrics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.YPED.2012.03.032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD Agents

  2011cited by this paper
• ADHD drugs and serious cardiovascular events in children and young adults.

  2011cited by this paper

• Echocardiographic Evaluation of the Effect of Long-Term Methylphenidate Use on Cardiovascular Functions

  2025cites this paper
• A Review and an Update on Pharmacological Treatment of Children With Attention-Deficit/Hyperactivity Disorder

  2025cites this paper
• Cerebrovascular diseases in ADHD patients with metabolic comorbidities: a retrospective cohort study

  2025cites this paper
• Association between methylphenidate use and long-term cardiovascular risk in paediatric patients with attention deficit and hyperactivity disorder

  2024cites this paper
• Incidence and trend of cardiac events among children and young adults exposed to psychopharmacological treatment (2006–2018): A nationwide register‐based study

  2024cites this paper
• Incidence of Neuroleptic Malignant Syndrome During Antipsychotic Treatment in Children and Youth: A National Cohort Study

  2024cites this paper
• Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates

  2023cites this paper
• An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder

  2023cites this paper
• Cardiovascular Safety of Atomoxetine and Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder in Japan: A Self-Controlled Case Series Study

  2023influential citation
• Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management

  2023cites this paper
• Safety of stimulant medications for attention deficit hyperactivity disorder in paediatric congenital heart disease

  2023cites this paper
• ChatGPT: First glance from a perspective of clinical pharmacology

  2023cites this paper
• An updated safety review of the current drugs for managing ADHD in children

  2023influential citation
• A phenome‐wide association study of polygenic scores for attention deficit hyperactivity disorder across two genetic ancestries in electronic health record data

  2022cites this paper
• Evaluation of Cardiovascular Effects of Methylphenidate in Children with Attention-deficit Hyperactivity Disorder

  2022cites this paper
• Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder

  2022cites this paper
• Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association

  2022cites this paper
• The role of ADHD genetic risk in mid-to-late life somatic health conditions

  2022cites this paper
• Fragile X Syndrome: From Molecular Aspect to Clinical Treatment

  2022cites this paper
• Circulation: Cardiovascular Quality and Outcomes

  2021cites this paper
• Acute myocardial infarction due to spontaneous coronary artery dissection in a 6-year-old boy with ADHD on the third day of treatment with methylphenidate

  2021cites this paper
• Stimulant Drugs of Abuse and Cardiac Arrhythmias

  2021cites this paper
• Stimulant Therapy Utilization for Neurocognitive Deficits in Mild Traumatic Brain Injury

  2021cites this paper
• Association between methylphenidate and risk of myocardial infarction: A multinational self‐controlled case series study

  2021cites this paper
• Mental Health in the Athlete: Modern Perspectives and Novel Challenges for the Sports Medicine Provider

  2020influential citation
• Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends

  2020cites this paper
• Medication Use for ADHD and the Risk of Driving Citations and Crashes Among Teenage Drivers: A Population-Based Cohort Study

  2020cites this paper
• Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis

  2020cites this paper
• Attention Deficit Hyperactivity Disorder

  2020cites this paper
• University of Groningen An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder

  2020cites this paper
• Early Life Stress, Growth and Neurodevelopment in Childhood

  2020cites this paper
• Sudden cardiac death in children and young adults without structural heart disease: a comprehensive review.

  2020cites this paper
• ADHD in Children: Common Questions and Answers.

  2020cites this paper
• Effects of medications on ventricular repolarization in children with attention deficit hyperactivity disorder

  2020cites this paper
• International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder

  2020cites this paper
• Big Data in the Assessment of Pediatric Medication Safety

  2020cites this paper
• Drug- and toxin-induced pulmonary arterial hypertension: Current state of the literature

  2020cites this paper
• Advances in the Use of Real‐World Evidence for Medical Devices: An Update From the National Evaluation System for Health Technology

  2019cites this paper
• Risks and benefits of ADHD medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases

  2019cites this paper
• NSS_A_218402 241..252

  2019cites this paper
• Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects

  2019cites this paper
• Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

  2019cites this paper
• Building Conceptions of Cognitive Enhancement: University Students’ Views on the Effects of Pharmacological Cognitive Enhancers

  2019cites this paper
• Abnormal Psychology

  2019cites this paper
• Real‐World Data, Advanced Analytics, and the Evolution of Postmarket Drug Safety Surveillance

  2019cites this paper
• Diving and attention deficit hyperactivity disorder.

  2019cites this paper
• Are the effects of methylphenidate uncertain?

  2018cites this paper
• Cardiovascular Events Following Treatment Initiation with Atypical Antipsychotic Medications in Publicly Insured U.S. Youth

  2018influential citation
• Prevalence of Dietary Supplement Use in US Children and Adolescents, 2003-2014

  2018cites this paper
• Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners.

  2018cites this paper
• The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention‐deficit/hyperactivity disorder and other psychiatric comorbidities

  2018cites this paper
• Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association

  2018cites this paper
• Patient-Centered Medical Homes and Parental Attention-Deficit Hyperactivity Disorder Medication Beliefs and Adherence

  2018cites this paper
• A Randomized Controlled Laboratory Study on the Long-Term Effects of Methylphenidate on Cardiovascular Function and Structure in Rhesus Monkeys

  2018cites this paper
• Effect of psychostimulants on blood pressure profile and endothelial function in narcolepsy

  2018cites this paper
• Attention Deficit–Hyperactivity Disorder and Month of School Enrollment

  2018cites this paper
• Effects of Long-Term Use of Prescription Methylphenidate on Myocardial Performance in Children with Attention-Deficit/Hyperactivity Disorder: A Tissue Doppler Imaging Study

  2018cites this paper
• Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

  2018cites this paper
• Optimal search strategies for identifying moderators and predictors of treatment effects in PubMed.

  2018cites this paper
• Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone.

  2017cites this paper
• The safety of extended-release drug formulations for the treatment of ADHD

  2017cites this paper
• The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials

  2017cites this paper
• Sudden Cardiac Death Decreasing: Why Remains Unclear

  2017cites this paper
• Movement and nutrition in health and disease

  2017cites this paper
• Non-medical and illicit use of psychoactive drugs

  2017cites this paper
• Amphetamines: Potent Recreational Drug of Abuse

  2017cites this paper
• Attention Deficit Hyperactivity Disorder: Unique Considerations in Athletes

  2017cites this paper
• An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder

  2017cites this paper
• ADHD medications and cardiovascular adverse events in children and adolescents: cross‐national comparison of risk communication in drug labeling

  2017cites this paper
• QT prolongation by dexamphetamine: Does experience matter?

  2017cites this paper
• Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine

  2017cites this paper
• Use of Unsolicited Patient Observations to Identify Surgeons With Increased Risk for Postoperative Complications

  2017cites this paper
• Blood pressure and anthropometry in children treated with stimulants: a longitudinal cohort study with an individual approach

  2017cites this paper
• Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism

  2017cites this paper
• Le traitement du Trouble Déficit Attentionnel-Hyperactivité par le méthylphénidate dans une perspective naturaliste critique. Une étude qualitative auprès d’adolescents

  2017cites this paper
• Pharmakotherapie der ADHS im Erwachsenenalter

  2017cites this paper
• Stimulant pharmacotherapy for adults with attention deficit hyperactivity disorder: cardiovascular effects and risk of sudden cardiac death

  2016cites this paper
• Adult ADHD Medications and Their Cardiovascular Implications

  2016cites this paper
• AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current evidence, knowledge gaps, recommendations and future directions

  2016cites this paper
• From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate

  2016cites this paper
• Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study

  2016cites this paper
• STEMI Secondary to Coronary Vasospasm: Possible Adverse Event of Methylphenidate in a 21-Year-Old Man with ADHD

  2016cites this paper
• Use of drugs for ADHD among adults—a multinational study among 15.8 million adults in the Nordic countries

  2016cites this paper
• Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence

  2016cites this paper
• ADHD in school-aged youth

  2016cites this paper
• Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial

  2016cites this paper
• Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study.

  2016cites this paper
• The cardiovascular safety of methylphenidate

  2016cites this paper
• Impact of Stimulant Medication Use on Heart Rate and Systolic Blood Pressure During Submaximal Exercise Treadmill Testing in Adolescents

  2016influential citation
• Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder

  2016cites this paper
• Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study

  2016cites this paper
• A Longitudinal Study of the Motivations for the Non-medical Use of Prescription Drugs in a National Sample of Young Adults

  2016cites this paper
• Stimulants and Pediatric Cardiovascular Risk

  2016cites this paper
• Pharmacotherapy of Aggression in Child and Adolescent Psychiatric Disorders

  2016cites this paper
• Manejo homeopático de pacientes con patologia que corresponde al trastorno por déficit de atención e hiperactividad

  2016cites this paper
• Attention‐Deficit Hyperactivity Disorder and Long‐QT Syndrome: Risky Business

  2015cites this paper
• An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.

  2015cites this paper
• Canadian Guidelines on Pharmacotherapy for Disruptive and Aggressive Behaviour in Children and Adolescents with Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, or Conduct Disorder

  2015cites this paper
• Long‐QT Syndrome and Therapy for Attention Deficit/Hyperactivity Disorder

  2015cites this paper
• Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?

  2015cites this paper